key: cord-0874823-geijlavn authors: Kalin, Sevinc; Ciraci, Saliha; Cakir, Deniz; Oysu, Aslihan Semiz; Sozeri, Betul; Demir, Ferhat; Bukte, Yasar title: Evaluation of radiological findings in pediatric patients with COVID-19 in Turkey date: 2021-08-25 journal: North Clin Istanb DOI: 10.14744/nci.2020.97947 sha: f9710974eb5d055451fe3bf5344dd2366914632b doc_id: 874823 cord_uid: geijlavn OBJECTIVE: The objective of the study was to describe the findings of pediatric patients diagnosed with COVID-19 in computed tomography (CT) and chest X-ray (CXR) images. Therefore, the aim of this study is to show protecting the children from radiation as much as possible while guiding the diagnosis. METHODS: Between March and June 2020, 148 pediatric patients examined who underwent CT due to suspicion of COVID-19. Fifty patients of 148 with normal thorax CT and negative reverse transcription polymerase chain reaction (RT-PCR) were excluded from the study. Of the remaining 98 patients were evaluated retrospectively by two pediatric radiologists with 15 years of experience. RESULTS: The demographic, clinical, and laboratory data were evaluated for 52 RT-PCR-positive patients. CT finding of 23 RT-PCR positive and 12 negative patients was classified. According to our study, unilateral (61–67%), multifocal (50–52%), and peripheral (83–91%) involvement were higher in all groups. Lower lobe involvement was frequently detected (58–65%). The most frequently detected parenchymal lesion was ground-glass opacity followed by consolidated areas accompanying ground-grass opacities. Halo sign and vascular enlargement signs were the common signs of lung lesions (35%). In addition, some rare findings not previously described in this disease in children were mentioned in this study. The clinical course of all our patients was mild and control radiological imaging checked by CXR. CONCLUSION: Most pediatric patients have a mild course. Hence, a balance between the risk of radiation and necessity for chest CT is very important. Low-dose CT scan is more suitable for pediatric patients but still it should be used cautiously. than 6 months [4] . COVID-19 pandemic and the seasonal winter-spring flu occurring at the same time made early and accurate diagnosis difficult in pediatric pneumonias. Patients diagnosed with COVID -19 may be clinically asymptomatic or may have a mortal course with a severe pneumonia [5, 6] . In adults, COVID-19 pneumonia has been described in many studies with its typical features in detail [7] . SARS-CoV-2 is less invasive in children than in adults. There are less radiological data due to the lower numbers of child patients and more limited use of computed tomography (CT) in children. To protect children especially from radiation, it is necessary to follow up with radiographs and decide on CT according to the clinical situation [7] . There are many limitations of using reverse transcription polymerase chain reaction (RT-PCR) test at diagnosis of COVID-19, and its sensitivity has been demonstrated in the range of 30-70%. However, the test being negative does not exclude the possibility of COVID-19 [8] . Chest radiographs have low sensitivity (20%) and are not the first imaging method to be preferred during early period of COVID-19 [9] . Chest CT has become the worldwide accepted imaging method for diagnosis and follow-up in suspected cases of adult patients with COVID-19. Compared to RT-PCR method, the sensitivity, specificity, and accuracy rates of CT were 97%, 25%, and 68%. The positive and negative predictive values were around 65% and 83%, respectively, for CT examination. In addition, we can see 60-93% positive CT findings before RT-PCR becomes positive [10] . Thorax CT and chest X-ray (CXR) examinations were evaluated in pediatric patients who were admitted to our hospital during the epidemic period and were diagnosed with COVID-19 by their clinical, laboratory, and radiological data. We describe the findings of chest CT and radiography in pediatric patients diagnosed with COVID-19 to guide the treatment in early diagnosis and clinical follow-up. At the same time, the aim of this study is to emphasize a balance between the risk of radiation and necessity for chest CT. The RT-PCR test used in isolation of SARS-CoV-2 was repeated 3 times for each patient. Clinical information, laboratory results, and epidemiological data of the patients were reviewed. Between March 15, and June 1, 2020, pediatric patients (0-18 age) who were referred to the radiology department with suspicion of COVID-19 pneumonia and underwent low-dose chest CT scan were included in the study. Patients with normal chest CT and negative PCR test were excluded from the study. The chest CT images of the pediatric patients with a positive PCR or abnormal chest CT findings were reviewed from the PACS and evaluated retrospectively by two pediatric radiologists with 15 years of experience. All examinations were carried out using the 128 detector Optima CT 660 SE (GE Healthcare, Milwaukee, USA) device available in our hospital in accordance with the low-dose CT protocol set for the pediatric patients. The patients were protected from unnecessary radiation using the automatic exposure control system in reference to the thoracic volume. Tube current exposure time product (mAs) value was in the range of 55-90, and the kilovolt (kv.) value was in the range of 80-100 in reference to the body volume of the patients. In thorax CT, both lung parenchyma (−700-+1500 HU) and mediastinal area (+50-+350 HU) were evaluated. Thorax CT was performed in a supine position without using contrast agent. In patients who could cooperate, the scan was performed at the end of inspiration. Images with adequate quality could not be obtained in some uncooperative patients. The Statistical Package for the Social Sciences (SPSS) (version 23.0, SPSS-Inc., Chicago, IL, USA) was used • Similar and different radiological findings have been described in children diagnosed with COVID-19 with lung parenchma involvement. In general, the course of the disease is seen to be milder in children compared to adults. Unfortunately, due to lack of clinical experience in the first mounts of pandemic, a large number of CT examinations were performed especially in adults. • In this process, we emphasize the choice of radiological examination by looking at reducing the number of radiological examinations and its contribution to the treatment process with our experience in children. for statistical analysis. Categorical data were presented as numbers and percentages. Chest CT scan was performed in 148 patients (78 males and 70 females) with clinical suspicion of COVID-19. Of these, 50 patients with negative RT-PCR tests and also normal CT were excluded from the study. Forty-six patients with negative RT-PCR tests and abnormal CT finding and 52 patients with positive RT-PCR test were included in this study (Fig. 1) . Demographic, clinical, and laboratory data of 52 patients with positive RT-PCR are demonstrated in Figure 1 . In group of 52 patients with positive RT-PCR test, 23 were male (44.2%), 29 were female (55.8%), and the median age was 13.37 (±4.8). The patients are categorized in five groups (Table 1 ). Most patients were in the group older than 15 years of age (42.3%). There were 40 patients with contact history (76.9%). The most common symptoms are cough (57.7%), respiratory distress (42.3%), and fever (21.2%). Comorbid disease was observed in 8 patients (15.4%) and hospitalization was required in 33 (63.5%) patients. Most of our patients had a mild course and completely healed. Pediatric multisystem inflammatory syndrome was observed in two of our patients. While leukocytosis was found in 5 patients (9.6%), lymphopenia was noted in 13 patients (25%). C-reactive protein (CRP) values were normal in 76% of patients and procalcitonin was <0.05 ng/ml in 94% of patients. In CT examination, there were no findings compatible with pneumonia in 29 (55.8%) of 52 patients with positive RT-PCR tests. In those 29 patients, CT findings were normal. In the RT-PCR-positive group, 23 of 52 (Group 1) patients had CT examinations compatible with COVID-19 pneumonia. In the group with negative RT-PCR test and CT findings consistent with pneumonia, 12 of 46 (Group 2) were diagnosed with COVID-19 by clinical observation and follow-up. The remaining 34 of 46 patients were diagnosed with other diseases during clinical and laboratory follow-up (other viral factors, bacterial pneumonia, aspiration pneumonia, etc.). Thorax CTs were classified according to the distribution of lesions and their appearance in CT (Table 2) . There was no need to repeat CT in patients who were diagnosed with COVID-19. Clinically, the patients had a mild course and followed up by CXR. Direct radiographs of Group 1 patients were evaluated. Only 4 (17.3%) of these patients had signs of pneumonia by CXR ( Fig. 2A) . Although there were signs of pneumonia in CT in the remaining 19 (82.7%) patients, CXRs were completely normal (Table 3) . Hazy hyperattenuated areas are typically caused by partial filling of air spaces by exudate or transudates without obstruction of the underlying vessels (Fig. 2B, 3A, B) . It is the earliest manifestation and may be with or without other CT findings. It is the most common CT finding, seen in up to 86.1% of our patients. Halo sign is a CT finding of ground-glass opacity surrounding a nodule or mass. It has been demonstrated in a variety of diseases, including the angioinvasive fungal infections, viral infections, organizing Thorax pneumonia, and hypervascular metastases. In our study, halo sign was presented in about 35% of patients (Fig. 4A) . Reversed halo sign defines a focal round GGO surrounded by complete or incomplete ring-like consolidation (Fig. 4B) . It used to be a pathognomonic CT finding for cryptogenic organizing pneumonia. Later, it was described in many diseases. In our pediatric COVID-19 group, reversed halo sign finding was present in only 1 patient (4.3%). Filling of the alveolar air spaces completely. As a result, we see hyperattenuated area with obscuration of underlying vessels (Fig. 5A ). Multifocal and peripheral consolidations were present in COVID-19 pneumonia. In our patients, consolidation was the second most common CT finding seen in up to 39.1%. To describe haziness or increased density around the walls of a bronchus or large bronchiole seen both on plain radiographs and on CT. It is present in only 2 patients (8.7%) in our study (Fig. 5A) . Dilatation of pulmonary vessels within the lesions, especially in GGO (Fig. 5A) . It was a quite common sign in our study (35%). Pleural thickening: Normal pleura is thinner than 1 mm. In the course of lung diseases, thickening may be accompanied by recurrent infections. This finding was present in only 2 patients (8.7%) in our study (Fig. 5B) . It refers to areas of decreased attenuation secondary to airway disease or pulmonary vascular disease which results from regional differences in lung perfusion. It was a rare CT finding at 2-3% (Fig. 6A, B) . In our study, this finding was defined in 2 patients (8.7%). According to our CT examination in patients diagnosed with COVID-19, unilateral involvement was higher in both groups (60.9% in Group 1 and 66.7% in Group 2). When we evaluated Table 1 , multilobar involvement was observed more frequently in Group 1, whereas unilobar involvement was relatively higher in Group 2. In both groups, multifocal and unifocal involvements were observed in approximately the same rate. The majority of the patients had disease involvement in the peripheral lung areas (1 st group 91% and 2 nd group 83%). Lower lobes were relatively more affected by the disease. In both groups, GGO (about 50%) is the most common appearance of the lesions in COVID-19. Second, consolidated areas accompanying ground-grass opacities were defined. The mosaic attenuation appearance was a less common finding and detected in three patients in our study (8.7% in Group 1and 25% in Group 2). Halo sign and vascular enlargement findings were the most common signs of the disease in lungs. In total, one patient had reversed halo sign and one patient had a tree in bud view. The number of patients diagnosed with COVID-19 at a pediatric age is much lower than in adults. Furthermore, we still have less CT data than adults because of the limited CT examination to protect pediatric patients from radiation. This study was conducted with the data of our center, which has a large potential for pediatric patients in the Anatolian side of Istanbul. In the early days of the pandemic, more patients were evaluated by CT due to the lack of clinical experience and panic behavior of their relatives. Afterward, the number of CT scans decreased as clinical experience increased so patients were followed up with CXR. When we examined the demographic, clinical, and laboratory data of 52 patients with positive RT-PCR test, we found that the most affected age group was between 11 and 17. Similar to the literature, most of our patients had a history of contact with a patient diagnosed with COVID-19. Clinical symptoms were presented in all of our patients and mostly we encountered cough, respiratory distress, and fever as in adults [5] [6] [7] 11] . According to the age groups, hospitalization rate was 80% in children under 11 years and 56% in children between 11 and 17 years old. Younger group of patients with comorbid disease was hospitalized longer than the older group. None of our patients needed intensive care. Similarly, in a study conducted by Dong et al. [11] It was reported that the clinical course was more severe in children under 1 year of age which had comorbid disease. When the laboratory data were examined, it was defined that leukocyte counts were normal in the patients (~90%) as stated in the literature, but approximately 25% of patients developed lymphopenia. Hospitalization period was longer in patients with lymphopenia compared to other groups. CRP values were observed to be normal in ~ approximately 77% of patients and procalcitonin was normal in almost all except three patients (<0.05 ng/ml). High procalcitonin may be a precursor of a secondary bacterial infection [5, 6, 12] . In this study, the clinical course was much milder in children diagnosed with COVID-19 compared to adults. CT was completely normal in 29 of 52 pediatric patients whose PCR test was positive. In the study of Steinberger et al. [13] with 30 pediatric patients, CT examination of 23 patients (77%) with COVID-19 was considered normal. In most of our pediatric patients with positive CT compatible with pneumonia, GGO, which was one of the typical findings defined for the disease, was observed. In most of the children with the findings of consolidation, which was the second most frequently observed, consolidations were accompanied by ground-glass opacities. This created the appearance of halo sign, which was one of the signs we frequently saw [14] [15] [16] . GGO was one of the most common CT findings and had been described in the literature in 80-98% of adult and pediatric patients [14, [17] [18] [19] . GGO was also one of the earliest manifestations of the disease [20] . It may or may not be accompanied by other findings, such as particularly consolidation and reticulation [21] . While 69% of our patients only had GGO, 26% of them had consolidations with GGO. Mosaic attenuation appearance was defined only in two of our patients and diffused all over the lung (8.7%). In these patients, clinical findings were more severe and length of hospitalization was longer than other patients (Fig. 5 ). This sign for COVID-19 was not defined in the literature. We defined vascular enlargement which was a relatively more specific sign in our pediatric patient group (around 35%). In the literature, it was stated that approximately 71.3-82.4% of adult COVID-19 patients had vascular enlargement [2, 22] . Thickened interlobular septa and intralobular lines which appeared as linear opacities on CT were defined as reticulation. Thickened interlobular septa or intralobular lines superimposed on GGO were defined as crazy-paving pattern. It was reported in 5-36% of patients with COVID-19 pneumonia [20, 23, 24] . Reticulation and crazy-paving pattern were common findings in adult age group in COVID-19 [2, [24] [25] [26] . In our study, we did not see neither of those findings. Reticulation was a relatively late finding compared to GGO and consolidation [27] . In our study, all patients were affected mildly and showed rapid recovery. According to the distribution of the lesions, unilateral involvement was defined more frequently in our pediatric patients, albeit with a slight difference. In the literature, bilateral lung involvement was mentioned more frequently in both pediatric age groups and adults. Unilateral involvement observed in both our study groups may be due to early diagnosis. In most of our patients, we defined multicentric peripheral lesions in lower lobes similar to the literature [15, 27] . Extrapulmonary lesions were rarely detected in this study as recorded in literature. Secondary bacterial infections may have been present in these patients. CXR may be used in COVID-19 pneumonia as the first imaging modality compared to CT with the advantages of less ionizing radiation. It has many advantages due to it being portable and its ease of sterilization. CXR of Group 1 was evaluated. Only four of these 23 patient' s pneumonia could be detected in CXR. Although there were signs of pneumonia in CT in 19 (82.7%) patients, CXRs were completely normal (Table 3) . Accordingly, the sensitivity of CXR was very low with 17% in this study. The sensitivity of CXR was not remarkably higher than the R-PCR test, ranges between 33% and 69% [28] . CXR may be useful in the diagnosis of other disease such as lobar pneumonia due to bacterial infections, pulmonary edema, pneumothorax, and pleural effusion that may mimic COVID-19 pneumonia. CXR may be helpful to evaluate the progression of diseases in hospitalized patients [29] . In the presence of high clinical suspicion and normal radiography, CT may be employed to detect diseases for a timely isolation and treatment of patients due to its sensitivity for early pneumonic changes [30] . CT appears to have a higher sensitivity than RT-PCR test reported that CT sensitivity was 97.2%, while RT-PCR test sensitivity was 83.3% [31] . CT may detect COVID-19 pneumonia in asymptomatic patients [32] . Despite its relatively high sensitivity, it is recommended to confirm the diagnosis of clinically suspected patients if the RT-PCR test is negative or unavailable, for to isolate and treat the patients quickly [33, 34] . We limited our CT numbers to protect children from radiation and not enough quality CT images could be obtained in uncooperated patients. Chest CT can demonstrate characteristic changes of multifocal, peripheral ground-glass opacities and consolidations with surrounding halo. When some chest CT characteristics of children with COVID-19 were atypical compared to adults, we found localized unilateral involvement, relatively rare interlobular septal thickening, and rare crazy-paving pattern. Most pediatric patients have a mild course. Hence, a balance between the risk of radiation and necessity for chest CT is very important. Low-dose CT scan is more suitable for pediatric patients but still it should be used cautiously. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Facing the pandemic of 2019 novel coronavirus infections: the pediatric perspectives Neonatal enterovirus infections: emphasis on risk factors of severe and fatal infections Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Essentials for radiologists on COVID-19: an update-radiology scientific expert panel Extension of coronavirus disease 2019 (COVID-19) on chest CT and implications for chest radiograph interpretation Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children Epidemiology of COVID-19 among children in China Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus CT features of coronavirus disease (COVID-19) in 30 pediatric patients Differences in clinical and imaging presentation of pediatric patients with COVID-19 in comparison with adults Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults CT imaging features of COVID-19 pneumonia: initial experience from Turkey The clinical and chest CT features associated with severe and critical COVID-19 pneumonia CT morphology of COVID-19: Case report and review of literature CT imaging features of 2019 novel coronavirus (2019-nCoV) Emerging 2019 novel coronavirus (2019-nCoV) pneumonia Coronavirus disease 2019 (COVID-19): role of chest CT in diagnosis and management Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19) Fleischner Society: glossary of terms for thoracic imaging Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the fleischner society Chest CT findings in cases from the cruise ship Diamond Princess with coronavirus disease (COVID-19) Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT? COVID-19 pneumonia: what has CT taught us? Radiological Society of North America Expert Consensus Document on Reporting Chest CT Findings Related to COVID-19: Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA Chest CT for typical coronavirus disease 2019 (COVID-19) pneumonia: relationship to negative RT-PCR testing Financial Disclosure: The authors declared that this study has received no financial support.